(Q45717902)
Statements
Recommendations for the design of Phase 3 pharmaceutical trials that are more informative for patients, clinicians, and payers (English)
Seema S Sonnad
Danielle Whicher
Jennifer C Goldsack
Penny E Mohr
scientific article published on 31 August 2013
No description defined